FKBP4P2

Across TCGA pan-cancer cohorts, FKBP4P2 RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated FKBP4P2 data layer.

The strongest signal is observed in mesothelioma (MESO), where higher FKBP4P2 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated FKBP4P2 expression acts as an unfavorable survival marker, although some lineages such as ESCA show a favorable association.

MESO, KIRC, and BLCA are the cancer types where FKBP4P2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	OS	Tertile	All	0.132	0.556	<.001	153	view →
KIRC	OS	Tertile	II,III,IV	0.339	0.733	<.001	84	view →
BLCA	OS	Tertile	IV	0.258	0.606	.016	24	view →
ESCA	DFS	Median	III,IV	0.540	0.300	.005	24	view →
THCA	OS	Tertile	III,IV	0.240	0.795	.006	21	view →
BRCA	OS	Tertile	II,III,IV	0.428	0.577	.037	12	view →
CHOL	OS	Tertile	All	0.155	0.725	.029	9	view →
STAD	DFS	Quartile	IV	0.095	0.528	.003	9	view →
HNSC	OS	Tertile	All	0.202	0.374	.039	3	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

FKBP4P2–MESO (OS)

Open the MESO breakdown →